Non-invasive profiling of protease-specific elastin turnover in lung cancer: biomarker potential
- 54 Downloads
Elastin is a signature protein of lungs. Increased elastin turnover driven by altered proteolytic activity is an important part of lung tumorigenesis. Elastin-derived fragments have been shown to be pro-tumorigenic, however, little is known regarding the biomarker potential of such elastin fragments. Here, we present an elastin turnover profile by non-invasively quantifying five specific elastin degradation fragments generated by different proteases.
Elastin fragments were assessed in serum from patients with stage I–IV non-small cell lung cancer (NSCLC) (n = 40) and healthy controls (n = 30) using competitive ELISAs targeting different protease-generated fragments of elastin: ELM12 (generated by matrix metalloproteinase MMP-9 and -12), ELM7 (MMP-7), EL-NE (neutrophil elastase), EL-CG (cathepsin G) and ELP-3 (proteinase 3).
ELM12, ELM7, EL-NE and EL-CG were all significantly elevated in NSCLC patients (n = 40) when compared to healthy controls (n = 30) (ELM12, p = 0.0191; ELM7, p < 0.0001; EL-NE, p < 0.0001; EL-CG, p < 0.0001). ELP-3 showed no significant difference between patients and controls (p = 0.8735). All fragments correlated positively (Spearman, r: 0.69–0.81) when compared pairwise, except ELM12 (Spearman, r: 0.042–0.097). In general, all fragments were detectable across all stages of the disease.
Elastin fragments generated by different proteases are elevated in lung cancer patients compared to healthy controls but differ in their presence. This demonstrates non-invasive biomarker potential of elastin fragments in serum from lung cancer patients and suggests that different pathological mechanisms may be responsible for the elastin turnover, warranting further validation in clinical trials.
KeywordsElastin MMP Neutrophil elastase Cathepsin g Proteinase 3 Biomarker Lung cancer NSCLC ECM Serum
We acknowledge the Danish Research Foundation for supporting this study.
Compliance with ethical standards
Conflict of interest
All authors are employed at Nordic Bioscience involved in biomarker discovery and assay development.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from all individual participants included in the study.
- Gminski J, Mykala-Ciesla J, Machalski M, Drozdz M (1993) Elastin metabolism parameters in sera of patients with lung cancer. Neoplasma 40:41–44Google Scholar
- Hofmann H-S, Hansen G, Richter G et al (2005) Matrix metalloproteinase-12 expression correlates with local recurrence and metastatic disease in non-small cell lung cancer patients. Clin Cancer Res 11:1086–1092Google Scholar
- Mithieux SM, Weiss AS (2005) Elastin. In: Advances in protein chemistry. Academic Press, Cambridge, pp 437–461Google Scholar
- Safranek J, Pesta M, Holubec L et al (2009) Expression of MMP-7, MMP-9, TIMP-1 and TIMP-2 mRNA in lung tissue of patients with non-small cell lung cancer (NSCLC) and benign pulmonary disease. Anticancer Res 29:2513–2517Google Scholar
- Yang JJ, Preston GA, Pendergraft WF et al (2001) Internalization of proteinase 3 is concomitant with endothelial cell apoptosis and internalization of myeloperoxidase with generation of intracellular oxidants. Am J Pathol 158:581–592. https://doi.org/10.1016/S0002-9440(10)64000-X CrossRefGoogle Scholar